Skip to content

Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses

Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05097105
Enrollment
50
Registered
2021-10-27
Start date
2021-11-30
Completion date
2023-11-30
Last updated
2021-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Bladder Neoplasm

Brief summary

Urinary bladder cancer is a common malignant tumor of the urinary tract in both men and women. Proper management of the urinary bladder cancer depends on the stage of the lesions. Differentiating the histopathological types, tumor grade and the depth of tumor invasion are very important for determining the therapeutic approach and are highly correlated with the recurrence, progression and patient's survival. Radical cystectomy (RC) and lymphadenectomy after neoadjuvant chemotherapy is the standard treatment for muscle invasive tumors, whereas the treatment of choice for non-muscle invasive tumors is transurethral resection (TUR) ±chemo/immunotherapy. Cystoscopy with biopsy is still the best tool for bladder cancer staging due to its high sensitivity in detecting lesions and the possibilities of tumor resections, but the main drawbacks are invasiveness, limitation in detection of flat lesions, and lack of the assessment of extra-vesical tumor invasion. Modern diagnostic modalities circumvent these limitations like blue-light cystoscopic examination and infrared cystoscopy. For the radiological evaluation of the urinary bladder, magnetic resonance imaging (MRI) is a valuable imaging modality due to high tissue contrast and multiplanar imaging capabilities. Diffusion-weighted images provides useful information for evaluation of local T stage of the urinary bladder cancer, specially in differentiating T1 stage or lower tumors from T2 stage and higher tumor stages. Apparent diffusion coefficient (ADC) delineating the degree of water molecular diffusion and the degree of restriction to water diffusion in biological tissues is inversely correlated to the integrity of the cell membranes and the tissue cellularity. The apparent diffusion coefficient (ADC) value has been revealed as quantitative measure of the degree of malignancy of the lesions. Decreased ADC values were reported with malignant lesions which have a larger cell diameter and more cellularity than normal tissue.

Interventions

DEVICEMRI

MRI sequences: TI. T2 and diffusion weighted

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

:• Age, any age will be included * Sex, both genders are included. * Patient presenting with heamaturia or intractable cystitis and urinary bladder mass lesions detected on ultrasound and/or CT examinations (with contrast).

Exclusion criteria

• General contraindications to MR imaging (pacemaker, metallic prostheses and clostrophobia).

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis of urinary bladder masses2 yearsdetection and grading of urinary bladder masses using ADC value and pattern of signal of restriction in diffusion weighted image .

Countries

Egypt

Contacts

Primary ContactWalaa R Abdellah, assistant lecture
walaa.mahmoud@med.sohag.edu.eg01099870794
Backup ContactMohammed TH Mahmoud, professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026